CHA University
Seongnam-si, Gyeonggi-do, 13503, South Korea
NCT Number: NCT07695441
This randomized crossover proof-of-concept study evaluated the effects of walking with a wearable hip exoskeleton on postprandial glycemic and physiological responses in healthy adults. Participants completed four experimental conditions: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode. The primary aim was to determine whether walking with the wearable hip exoskeleton alters postprandial glucose responses compared with seated control and conventional walking conditions.
Looking for future studies?
Notify Me20 year–65 year
All sexes
Interventional
Not applicable
Seongnam-si, Gyeonggi-do, 13503, South Korea
This study investigated whether walking with a wearable hip exoskeleton could modulate postprandial glycemic and physiological responses in healthy adults. Using a randomized crossover design, each participant completed four experimental conditions in a controlled laboratory setting: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode.
Postprandial glucose responses were assessed after meal ingestion during each experimental trial. Physiological responses, including heart rate, perceived exertion, and energy expenditure, were also evaluated to compare the metabolic and perceptual demands of walking with and without the wearable hip exoskeleton. The study was designed as a proof-of-concept trial to examine whether wearable hip exoskeleton-assisted walking may influence postprandial glucose regulation in healthy adults.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants performed walking without wearing the Bot-Fit wearable hip exoskeleton during the postprandial period.
Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Aqua mode during the postprandial period.
Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Boost mode during the postprandial period.
Time frame: Up to 120 minutes after meal ingestion during each experimental trial
Incremental area under the curve for postprandial glucose was calculated during the postprandial measurement period for each experimental condition.
Time frame: Up to 120 minutes after meal ingestion during each experimental trial
The peak glucose concentration observed during the postprandial measurement period was compared across experimental conditions.
Time frame: From the start to the end of the 30-minute intervention or control period on each experimental trial day
Heart rate was assessed during each experimental condition to evaluate physiological responses to walking with and without the wearable hip exoskeleton.
Time frame: Immediately after each experimental condition
Rating of perceived exertion was assessed to compare subjective exercise intensity across walking conditions.
CHA University
Other
Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Healthy Adults: A Randomized Crossover Proof-of-Concept Study
Acronym: Bot-Fit Health
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05783752
Glucose Metabolism Disorders, Hyperglycemia
San Diego, California, United States
View Trial DetailsNCT05587426
Postprandial Glycemic Response
Toronto, Ontario, Canada
View Trial DetailsNCT07454551
Healthy Adults, Young
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05379101
Amyloid Neuropathies, Amyloid Neuropathies, Familial
Rochester, Minnesota, United States
View Trial Details